IL10 and hepatocellular carcinoma: In a larger series of 222 subjects with unresectable HCC (predominantly HBV related), the overall survival of patients with high serum IL-10 levels was significantly worse than that of the low IL-10 group (hazard ratio [HR] 2.2) [102].